CTNM
Contineum Therapeutics, Inc.
-0.62 (-4.51%)13.14USD176K成交股數304M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 10 · 1.1M · 3 |
| 其中 10b5-1 計畫賣出 | 10 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 1.2M |
| 近 180 天 淨額 | −1.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 09-08 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 2.5K | 16.46 | 41K | 17.2K | SEC |
| 2026-09-08 | 09-08 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 2.5K | 1.01 | 3K | 19.7K | SEC |
| 2026-08-03 | 08-03 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 2.5K | 1.01 | 3K | 19.7K | SEC |
| 2026-08-03 | 08-03 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 2.5K | 16.01 | 40K | 17.2K | SEC |
| 2026-07-09 | 07-10 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 25 | 1.01 | 25.25 | 135K | SEC |
| 2026-07-09 | 07-10 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 25 | 16.00 | 400.00 | 135K | SEC |
| 2026-07-08 | 07-10 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.0K | 16.00 | 16K | 135K | SEC |
| 2026-07-08 | 07-10 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 1.0K | 1.01 | 1K | 136K | SEC |
| 2026-07-08 | 07-08 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 2.5K | 1.01 | 3K | 19.7K | SEC |
| 2026-07-08 | 07-08 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 2.5K | 16.00 | 40K | 17.2K | SEC |
| 2026-07-01 | 07-02 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 4.2K | 1.01 | 4K | 144K | SEC |
| 2026-07-01 | 07-02 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.5K | 16.24 | 41K | 135K | SEC |
| 2026-07-01 | 07-02 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.9K | 15.67 | 92K | 138K | SEC |
| 2026-06-30 | 07-02 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 28.8K | 1.01 | 29K | 168K | SEC |
| 2026-06-30 | 07-02 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 28.8K | 16.04 | 462K | 139K | SEC |
| 2026-06-30 | 07-01 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 7.5K | 1.01 | 8K | 24.7K | SEC |
| 2026-06-30 | 07-01 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 2.5K | 1.26 | 3K | 27.2K | SEC |
| 2026-06-30 | 07-01 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 10.0K | 16.01 | 160K | 17.2K | SEC |
| 2026-06-30 | 07-01 | Watkins Tim | CMO & Head of Development | M 選擇權執行 | 10.8K | 4.50 | 49K | 19.8K | SEC |
| 2026-06-30 | 07-01 | Watkins Tim | CMO & Head of Development | S 公開市場賣出(10b5-1) | 10.8K | 16.02 | 174K | 9.0K | SEC |
| 2026-06-01 | 06-01 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.2K | 13.16 | 55K | 139K | SEC |
| 2026-05-01 | 05-01 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 300 | 13.84 | 4K | 144K | SEC |
| 2026-05-01 | 05-01 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.9K | 13.06 | 51K | 144K | SEC |
| 2026-04-06 | 04-06 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.2K | 13.43 | 56K | 148K | SEC |
| 2026-03-02 | 03-02 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.2K | 15.01 | 63K | 152K | SEC |
| 2026-03-02 | 03-02 | Watkins Tim | CMO & Head of Development | M 選擇權執行 | 3.6K | 4.50 | 16K | 3.6K | SEC |
| 2026-03-02 | 03-02 | Watkins Tim | CMO & Head of Development | S 公開市場賣出(10b5-1) | 3.6K | 15.02 | 54K | 0 | SEC |
| 2026-02-25 | 02-26 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 2.7K | 16.02 | 43K | 15.0K | SEC |
| 2026-02-25 | 02-26 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 2.7K | 1.26 | 3K | 17.7K | SEC |
| 2026-02-25 | 02-26 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 3.8K | 1.01 | 4K | 160K | SEC |
| 2026-02-25 | 02-26 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.8K | 16.01 | 61K | 156K | SEC |
| 2026-02-24 | 02-26 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 4.4K | 1.26 | 6K | 19.4K | SEC |
| 2026-02-24 | 02-26 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 4.3K | 1.01 | 4K | 160K | SEC |
| 2026-02-24 | 02-26 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.3K | 16.03 | 69K | 156K | SEC |
| 2026-02-24 | 02-26 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 4.4K | 16.02 | 70K | 15.0K | SEC |
| 2026-02-19 | 02-20 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 100 | 1.01 | 101.00 | 156K | SEC |
| 2026-02-19 | 02-20 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 100 | 16.00 | 2K | 156K | SEC |
| 2026-02-11 | 02-13 | Lorrain Daniel S. | Chief Scientific Officer | M 選擇權執行 | 400 | 1.01 | 404.00 | 156K | SEC |
| 2026-02-11 | 02-13 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 400 | 16.00 | 6K | 156K | SEC |
| 2026-02-11 | 02-13 | Stengone Carmine N. | CEO and President | M 選擇權執行 | 400 | 1.26 | 504.00 | 15.4K | SEC |
| 2026-02-11 | 02-13 | Stengone Carmine N. | CEO and President | S 公開市場賣出(10b5-1) | 400 | 16.00 | 6K | 15.0K | SEC |
| 2026-02-03 | 02-05 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.0K | 14.82 | 44K | 157K | SEC |
| 2026-02-03 | 02-05 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.2K | 15.25 | 18K | 156K | SEC |
| 2026-01-28 | 01-30 | Watkins Tim | CMO & Head of Development | M 選擇權執行 | 3.6K | 4.50 | 16K | 3.6K | SEC |
| 2026-01-28 | 01-30 | Watkins Tim | CMO & Head of Development | S 公開市場賣出(10b5-1) | 2.8K | 14.09 | 39K | 811 | SEC |
| 2026-01-28 | 01-30 | Watkins Tim | CMO & Head of Development | S 公開市場賣出(10b5-1) | 811 | 14.48 | 12K | 0 | SEC |
| 2026-01-05 | 01-06 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.7K | 10.35 | 38K | 161K | SEC |
| 2026-01-05 | 01-06 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 500 | 11.13 | 6K | 160K | SEC |
| 2025-12-29 | 12-30 | Watkins Tim | CMO & Head of Development | M 選擇權執行 | 3.6K | 4.50 | 16K | 3.6K | SEC |
| 2025-12-29 | 12-30 | Watkins Tim | CMO & Head of Development | S 公開市場賣出(10b5-1) | 3.6K | 12.06 | 44K | 0 | SEC |
| 2025-12-23 | 12-30 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.2K | 12.23 | 51K | 164K | SEC |
| 2024-11-25 | 11-27 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.0K | 16.02 | 16K | 169K | SEC |
| 2024-11-18 | 11-20 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 99 | 17.05 | 2K | 170K | SEC |
| 2024-11-18 | 11-20 | Lorrain Daniel S. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.1K | 16.37 | 100K | 170K | SEC |
| 2024-08-13 | 08-14 | Huhn Stephen L. | CMO & Sr VP, Clinical Dev. | M 選擇權執行 | 12.8K | 1.01 | 13K | 12.8K | SEC |
| 2024-04-09 | 04-11 | Versant Venture Capital VI, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I, L.P. | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I, L.P. | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP, L.P. | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP, L.P. | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP-GP, LLC | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP-GP, LLC | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP-GP, LLC | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP-GP, LLC | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP-GP, LLC | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Vantage I GP-GP, LLC | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP, L.P. | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP, L.P. | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures VI GP, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures IV, LLC | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures IV, LLC | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Ventures IV, LLC | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Venture Capital IV, L.P. | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Venture Capital IV, L.P. | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Venture Capital IV, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
| 2024-04-09 | 04-11 | Versant Side Fund IV, L.P. | TenPercentOwner | C 轉換 | 392K | – | – | 392K | SEC |
| 2024-04-09 | 04-11 | Versant Side Fund IV, L.P. | TenPercentOwner | C 轉換 | 2.5K | – | – | 2.5K | SEC |
| 2024-04-09 | 04-11 | Versant Side Fund IV, L.P. | TenPercentOwner | C 轉換 | 148K | – | – | 148K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 2.8M | 46.6M | 不變 | 持平 |
| Jupiter Topco LLC | 2.7M | 44.8M | 新進 | 新進 |
| BlackRock, Inc. | 2.1M | 33.8M | +1.4M (+209%) | 加碼 |
| JOHNSON & JOHNSON | 2.0M | 32.4M | 不變 | 持平 |
| FRANKLIN RESOURCES INC | 1.8M | 30.1M | 不變 | 持平 |
| Balyasny Asset Management L.P. | 1.5M | 25.0M | −163K (-10%) | 減碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | 21.7M | +107K (+9%) | 加碼 |
| PERCEPTIVE ADVISORS LLC | 1.3M | 20.6M | 不變 | 持平 |
| FMR LLC | 1.0M | 17.0M | +225K (+28%) | 加碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 932K | 15.3M | −604K (-39%) | 減碼 |
| GREAT POINT PARTNERS LLC | 921K | 15.1M | +121K (+15%) | 加碼 |
| Longaeva Partners L.P. | 813K | 13.3M | +80.7K (+11%) | 加碼 |
| Ikarian Capital, LLC | 808K | 13.2M | 不變 | 持平 |
| SECTORAL ASSET MANAGEMENT INC | 728K | 11.9M | 不變 | 持平 |
| GEODE CAPITAL MANAGEMENT, LLC | 693K | 11.4M | +411K (+146%) | 加碼 |
| HHLR ADVISORS, LTD. | 669K | 11.0M | 不變 | 持平 |
| RED TREE MANAGEMENT, LLC | 638K | 10.5M | 不變 | 持平 |
| Versant Venture Management, LLC | 543K | 8.9M | 不變 | 持平 |
| GOLDMAN SACHS GROUP INC | 497K | 8.2M | +190K (+62%) | 加碼 |
| Boxer Capital Management, LLC | 494K | 8.1M | 不變 | 持平 |
| STATE STREET CORP | 426K | 7.0M | +325K (+321%) | 加碼 |
| 城堡 CITADEL ADVISORS LLC | 396K | 6.5M | +46.2K (+13%) | 加碼 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 328K | 5.4M | 新進 | 新進 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 296K | 4.9M | −5.6K (-2%) | 減碼 |
| ADAR1 Capital Management, LLC | 279K | 4.6M | +2.3K (+1%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 102 +12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 29 / 17 / 31 / 19 |
| 機構合計持股 · 佔流通股 | 30.5M · 100.0% |
| 合計季末市值 | 500M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.3M |
|---|---|
| 與上期比 | +0.2% |
| 佔流通股數 | 10.13% |
| 日均成交量 | 583K |
| 回補天數 | 4.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.3M | +0.2% | 10.13% | 583K | 4.0 |
| 2026-08-14 | 2.3M | -17.2% | 10.12% | 524K | 4.5 |
| 2026-07-31 | 2.8M | +15.5% | 12.22% | 209K | 13.5 |
| 2026-07-15 | 2.4M | +14.3% | 10.58% | 334K | 7.3 |
| 2026-06-30 | 2.1M | +29.2% | 9.25% | 720K | 3.0 |
| 2026-06-15 | 1.7M | +15.6% | 7.16% | 218K | 7.6 |
| 2026-05-29 | 1.4M | +1.0% | 6.20% | 153K | 9.4 |
| 2026-05-15 | 1.4M | -11.7% | 6.14% | 210K | 6.7 |
| 2026-04-30 | 1.6M | -48.2% | 6.95% | 239K | 6.7 |
| 2026-04-15 | 3.1M | +11.5% | 13.42% | 243K | 12.7 |
| 2026-03-31 | 2.8M | +5.2% | 12.03% | 466K | 6.0 |
| 2026-03-13 | 2.6M | +3.7% | 11.44% | 265K | 10.0 |
| 2026-02-27 | 2.5M | -1.3% | 11.03% | 161K | 15.9 |
| 2026-02-13 | 2.6M | -0.6% | 11.18% | 231K | 11.2 |
| 2026-01-30 | 2.6M | +0.3% | 11.24% | 266K | 9.8 |
| 2026-01-15 | 2.6M | +5.5% | 11.21% | 270K | 9.6 |
| 2025-12-31 | 2.5M | +44.0% | 10.62% | 230K | 10.7 |
| 2025-12-15 | 1.7M | +62.4% | 7.37% | 266K | 6.4 |
| 2025-11-28 | 1.0M | -11.9% | 4.54% | 251K | 4.2 |
| 2025-11-14 | 1.2M | -2.7% | 5.15% | 123K | 9.7 |
| 2025-10-31 | 1.2M | +6.6% | 5.30% | 88.1K | 13.9 |
| 2025-10-15 | 1.1M | -4.3% | 4.97% | 94.4K | 12.2 |
| 2025-09-30 | 1.2M | +36.4% | 5.20% | 251K | 4.8 |
| 2025-09-15 | 880K | +41.9% | 3.81% | 203K | 4.3 |
| 2025-08-29 | 621K | +42.6% | 2.69% | 372K | 1.7 |
| 2025-08-15 | 435K | +63.5% | 1.88% | 132K | 3.3 |